Bacteriophage Therapy Market Poised to Witness High Growth Owing to Increasing Prevalence of Antibiotic-Resistant Bacterial Infections

The global bacteriophage therapy market is witnessing significant growth due to increasing prevalence of antibiotic-resistant bacterial infections. Bacteriophages or bacterial viruses are viruses that infect and replicate inside bacteria. They can be used to treat pathogenic bacterial infections and have gained increasing attention as an alternative to conventional antibiotics due to the emergence of multi-drug resistant bacteria. Bacteriophage therapy involves the use of lytic bacteriophages to infect and destroy specific pathogenic bacterial strains without harming other bacteria in the human microflora. It is highly specific and effective against the targeted bacterial strain. The ability of bacteriophages to self-replicate at the site of infection also increases their effectiveness as they multiply until all the host bacteria are destroyed.

The Global bacteriophage therapy market is estimated to be valued at US$ 50.24 Bn in 2024 and is expected to exhibit a CAGR of 24% over the forecast period 2024 to 2030.

Bacteriophage Therapy Market
null

Key Takeaways

Key players operating in the bacteriophage therapy market are General Dynamics, Airbus, Nordam, Saint-Gobain, Meggitt, Starwin Industries, Kitsap Composites, Orbital ATK, Jenoptik, Harris, Vermont Composites, Pacific Radomes, Royal Engineered Composites, AVIC, ATK, Kelvin Hughes, Raytheon, Leonardo, Ducommun, CPI. These players are focusing on new product launches and strategic collaborations to expand their share in the market.

The emergence of antibiotic-resistant bacteria along with the increasing prevalence of various bacterial infections is anticipated to offer significant growth opportunities to bacteriophage therapy manufacturers over the forecast period. The demand for alternative treatment options for bacterial infections is expected to drive the adoption of bacteriophage therapy globally.

European countries, especially the UK, France, Germany and Russia, have widely accepted bacteriophage therapy and registered phage therapeutic products. Companies are expanding their operations in Europe to leverage its large addressable market. Manufacturers are also focusing on countries in Asia Pacific and Latin America for further expansion owing to limited availability of antibiotics in these regions.

Market Drivers
Growing global threat of antimicrobial resistance - Increasing prevalence of antimicrobial resistance due to overuse and misuse of conventional antibiotics is a major driver for the Bacteriophage Therapy Market Growth. Phages are considered viable alternatives to treat antibiotic-resistant infections.
Efficacy against biofilms - Bacteriophages are highly effective against bacterial biofilms formed on medical devices, prostheses and tissues, making them suitable for a wide array of clinical applications.

Market Restraints
Limited understanding of phage biology - Complex nature of interactions between phages and host bacteria needs deeper understanding to ensure safety, efficacy and quality of phage therapeutics.
Stringent regulatory framework - Regulatory requirements for phage therapeutics differ in various regions. Obtaining approvals and conducting clinical trials is a long and costly process hampering market growth.

Segment Analysis
This market is dominated by Targeted phages sub segment. This sub segment comprises individually tailored phage preparations active against a known bacterial host. These are preferred over Phage cocktails as they provide high specificity against a particular strain of bacteria. They are being increasingly used in treatments of chronic infections that fail to respond to antibiotics.

Global Analysis
North America region holds the largest market share currently. High healthcare expenditure and increasing focus on development of innovative therapeutics are driving growth in this region. Asia Pacific region is expected to witness highest growth during forecast period owing to rising incidence of antibiotic resistant infections in developing economies and initiatives by governments to promote indigenous bacteriophage therapy research. Europe also captures a significant share due to supportive regulatory environment and established pharmaceutical industry. Promising clinical trials results indicate huge potential in Latin America and Middle East & Africa regions.

Comments

Post a Comment

Popular posts from this blog

Dolomite: A promising mineral for construction and agriculture industries

Image
Importance of Dolomite in construction Dolomite is one of the primary minerals used in construction industry globally. It is mainly used as an aggregate in road construction, concrete production and railway ballast. Dolomite aggregate is widely used in road construction due to its ability to withstand pressure and impact. Its high strength and durability makes it a suitable material for constructing highways, roads and bridges. Being resistant to weathering, dolomite roads last longer compared to other aggregates. Apart from aggregates, Dolomite is also used as a fluxing agent during steel manufacturing. Finely powdered dolomite is mixed with other fluxing materials in steel furnaces. The calcium-magnesium content of dolomite lowers the melting point and viscosity of slag, facilitating the steel making process. Dolomite flux also improves the fluidity and protects refractory linings of blast furnaces and basic oxygen furnaces. Another major construction application of dolomite is i
Read more

Endocrine Therapy Drugs: The Future of Cancer Treatment

Image
Endocrine therapy drugs (ETDs) have emerged as a breakthrough in the treatment of hormone-receptor positive cancers like breast, prostate and gynecological cancers. These targeted drugs work by blocking the effects of certain hormones like estrogen and progesterone that fuel the growth of cancer cells. With continuous advancements in research, ETDs are revolutionizing cancer management and improving outcomes for millions of patients worldwide. Types of ETDs A wide range of ETDs are available today which can be broadly classified into following categories: Aromatase Inhibitors Aromatase inhibitors like anastrozole, letrozole and exemestane work by blocking the enzyme aromatase which is responsible for the formation of estrogen in tissues. By reducing estrogen levels in the body, these drugs deprive hormone receptor positive breast cancer cells of the fuel required for their growth and proliferation. They are primarily used in postmenopausal women as a treatment for hormone recept
Read more

The Toxic Chemical Lurking in Our Daily Products: The Issue of Bisphenol A

Image
 Bisphenol A: An Overview Bisphenol A, commonly known as BPA, is a synthetic chemical that is primarily used in the production of polycarbonate plastics and epoxy resins. First developed in 1891, BPA acts as a monomer in the production of plastics and resins. These materials provide strength, durability and clarity to a wide range of products. However, over time, studies have linked BPA exposure to several health risks in both humans and animals. Prevalence in Daily Life BPA is highly prevalent in our daily lives due to its use in a variety of common consumer products and food containers. It is found in hard, clear plastic bottles for water as well as plastic containers and packaging for various canned and frozen foods. The chemical is also used in dental sealants and coatings on metal products like food cans. Even thermal paper commonly used for printing sales receipts contains BPA and leads to human exposure. The widespread use of BPA means humans are regularly exposed through our
Read more